← Open Payments lookup

KEVIN HO: Open Payments

NPI 1811587116 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$852 in 25 payments from 10 companies in 2025. Trend: 2023 $1,510 · 2024 $327 · 2025 $852

Food & beverage: $852
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.11$343
Teva Pharmaceuticals USA, Inc.2$92
Vanda Pharmaceuticals Inc.1$89
Otsuka America Pharmaceutical, Inc.1$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$71
Axsome Therapeutics, Inc.3$67
Lundbeck LLC2$40
Janssen Pharmaceuticals, Inc2$31
Alkermes, Inc.1$23
ABBVIE INC.1$18

Products named: COBENFY, UZEDY, FANAPT, ABILIFY MAINTENA, CAPLYTA, Auvelity, ABILIFY ASIMTUFII, INVEGA SUSTENNA.

Industry payments across MS — which companies pay providers there.